CII appoints Manni Kantipudi and Manoj Kumar R. Panicker to lead CRDMO task force
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Industry body aims to strengthen policy advocacy, innovation, and global competitiveness of India's fast-growing CRDMO sector
Deploys $40 million in Hyderabad; advances APIs, peptides, and global small molecule capabilities
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
His career spans notable tenures at Syngene International Limited, Cipla, Nestlé, and Bharat Petroleum Corporation Limited
Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical value-chain
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Postal ballot also clears remuneration proposal and new ESOP 2026 scheme, strengthening the company’s leadership and talent retention strategy
Enhanced CMC infrastructure at Cranbury site aims to improve bioavailability, streamline formulation development and support faster progression of challenging drug candidates into clinical trials
Subscribe To Our Newsletter & Stay Updated